EMBARC Clinical Research Symposium 2026

The EMBARC Clinical Research Symposium 2026 is a premier gathering for healthcare professionals, clinical researchers, and patient advocates dedicated to the study and treatment of non-cystic fibrosis bronchiectasis. Hosted by the University of Dundee—a world-leading hub for respiratory research led by Professor James Chalmers—this event serves as the central annual forum for the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC).

The 2026 symposium will focus on the "Next Frontier of Precision Medicine in Respiratory Care." Over two intensive days, delegates will explore the latest data from the European Bronchiectasis Registry, which now tracks thousands of patients across more than 30 countries. The program is designed to bridge the gap between bench-side research and bedside clinical practice, featuring keynote lectures from international experts, oral abstract presentations from rising stars in the field, and interactive panel discussions.

Key themes for the 2026 meeting include the impact of antimicrobial resistance on chronic lung infections, the development of new biological therapies, and the integration of digital health tools in long-term patient monitoring. Additionally, a significant portion of the event is dedicated to the Patient Advisory Group (PAG), ensuring that the lived experiences of those with bronchiectasis directly inform future research priorities.

Attendees will have the opportunity to participate in specialized breakout sessions covering:

1. Translational Science: Examining the pathophysiology of airway inflammation.

2. Clinical Trials: Updates on Phase II and III trials for novel anti-inflammatory and mucoactive agents.

3. Registry Data Analysis: Training on how to utilize EMBARC’s open-access data for local research initiatives.

Located in the heart of Dundee, the City of Discovery, this symposium provides an unparalleled networking environment. Whether you are a senior consultant, a PhD student, or a healthcare policymaker, the EMBARC Symposium offers the insights and connections necessary to advance the standard of care for bronchiectasis patients worldwide.